SCHEMBL7207196

SCHEMBL7207196

COc1ccc(S(=O)(=O)CC(CO)NC(=O)CNC(=O)OCc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 4/20 0.49
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
ACHE P22303 2/20 0.47
ATM Q13315 1/20 0.46
MMP2 P08253 2/20 0.43
MMP3 P08254 2/20 0.43
CYP3A4 P08684 2/20 0.43
MAPK1 P28482 1/20 0.42
CTSL P07711 1/20 0.42
CTSS P25774 1/20 0.42
CTSK P43235 1/20 0.42
PDE4A P27815 2/20 0.42
PDE4B Q07343 2/20 0.42
PDE4C Q08493 2/20 0.42
PDE4D Q08499 2/20 0.42
TSHR P16473 1/20 0.42
MMP1 P03956 3/20 0.41
ALDH1A1 P00352 2/20 0.41
MMP9 P14780 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7207971 0.91 MMP13 (0.48) MMP13CA1CA2ACHEATM
SCHEMBL7867074 0.79 MMP13 (0.51) MMP13CA1CA2ACHEATM
SCHEMBL7869903 0.77 MMP13 (0.57) MMP13CA1CA2ACHEATM
SCHEMBL7208364 0.77 MMP13 (0.52) MMP13CA1CA2MMP2CYP3A4
SCHEMBL7207972 0.76 MMP1 (0.45) MMP13CA1CA2ACHEATM
SCHEMBL7862165 0.76 NPC1 (0.52) MMP13CA1CA2MMP2MMP3
SCHEMBL7185942 0.75 MMP13 (0.67) MMP13CA2MMP2MMP3CYP3A4
SCHEMBL7185940 0.75 MMP13 (0.67) MMP13CA2MMP2MMP3CYP3A4
SCHEMBL10883284 0.75 KMT2A (0.59) ATMCTSLCTSSCTSKALDH1A1
SCHEMBL8601705 0.74 MMP13 (0.49) MMP13CA1CA2ACHEATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0939628-B1 THIOL SULFONE METALLOPROTEASE INHIBITORS MONSANTO CO (US) 2003-03-05 EP disclosed
US-6013649-A BOND DISORDERS; AUTOIMMUNE DISEASES; ANTITUMOR AGENTS MONSANTO COMPANY (US) 2000-01-11 US disclosed